A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma.

Saved in:
Bibliographic Details
Title: A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma.
Authors: Cote GM; Mass General Cancer Center, Boston, Massachusetts, USA., Conley AP; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Attia S; Mayo Clinic in Florida, Jacksonville, Florida, USA., Van Tine BA; Washington University School of Medicine, St. Louis, Missouri, USA., Seetharam M; Mayo Clinic in Arizona, Phoenix, Arizona, USA., Chen YL; Mass General Cancer Center, Boston, Massachusetts, USA., Gafoor Z; BNC Affiliation, Bavarian Nordic Inc, Durham, North Carolina, USA., Heery C; BNC Affiliation, Bavarian Nordic Inc, Durham, North Carolina, USA., Pico-Navarro C; BNC Affiliation, Bavarian Nordic Inc, Durham, North Carolina, USA., Adams T; BNM Affiliation, Bavarian Nordic GmbH, Martinsried, Germany.
Source: Cancer [Cancer] 2024 Nov 15; Vol. 130 (22), pp. 3845-3854. Date of Electronic Publication: 2024 Jul 10.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38985843
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cote+GM%22">Cote GM</searchLink>; Mass General Cancer Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Conley+AP%22">Conley AP</searchLink>; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Attia+S%22">Attia S</searchLink>; Mayo Clinic in Florida, Jacksonville, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Van+Tine+BA%22">Van Tine BA</searchLink>; Washington University School of Medicine, St. Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Seetharam+M%22">Seetharam M</searchLink>; Mayo Clinic in Arizona, Phoenix, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Chen+YL%22">Chen YL</searchLink>; Mass General Cancer Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Gafoor+Z%22">Gafoor Z</searchLink>; BNC Affiliation, Bavarian Nordic Inc, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Heery+C%22">Heery C</searchLink>; BNC Affiliation, Bavarian Nordic Inc, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Pico-Navarro+C%22">Pico-Navarro C</searchLink>; BNC Affiliation, Bavarian Nordic Inc, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Adams+T%22">Adams T</searchLink>; BNM Affiliation, Bavarian Nordic GmbH, Martinsried, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2024 Nov 15; Vol. 130 (22), pp. 3845-3854. <i>Date of Electronic Publication: </i>2024 Jul 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38985843
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cncr.35477
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3845
    Titles:
      – TitleFull: A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cote GM
      – PersonEntity:
          Name:
            NameFull: Conley AP
      – PersonEntity:
          Name:
            NameFull: Attia S
      – PersonEntity:
          Name:
            NameFull: Van Tine BA
      – PersonEntity:
          Name:
            NameFull: Seetharam M
      – PersonEntity:
          Name:
            NameFull: Chen YL
      – PersonEntity:
          Name:
            NameFull: Gafoor Z
      – PersonEntity:
          Name:
            NameFull: Heery C
      – PersonEntity:
          Name:
            NameFull: Pico-Navarro C
      – PersonEntity:
          Name:
            NameFull: Adams T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 11
              Text: 2024 Nov 15
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0142
          Numbering:
            – Type: volume
              Value: 130
            – Type: issue
              Value: 22
          Titles:
            – TitleFull: Cancer
              Type: main
ResultId 1